 | ||
   | ||
Email
Glossary |
|
New products; any news ? Aug 22, 2002 Is there any new information about second generation nnrti's that can hold out against resistance to the current class? If so how far in the future before you think they would be available for public consumption(fda approved)? Also how about intergrase inhibitors?Thank you |
||||||||
 |
||||||||||
|
||||||||||
 |
| Response from Dr. Young
 Thanks for your questions. There are a couple of so-called second-generation NNRTIs in the pipeline; these products are still some time away from large scale, pivotal studies. Two to watch are Tibotec's TMC125 compound and capravirine, from Agouron/Pfizer. FDA approval, if all goes well could still be a couple or three years away. As for integrase inhibitors, two companies (Merck and Shionogi/GSK) have candidate compounds that have entered early human clinical trials (Phase I or Phase II). Preliminary efficacy data from these trials might still be 6-12 months away, and yet an additional 2-3 years before pivotal studies are completed. Stay tuned, these compounds could very well be very important drugs in the years to come. -BY | ||||||||
 Get Email Notifications When This Forum Updates or Subscribe With RSS
|
||||||||||
|
||||||||||
Q&A TERMS OF USE
This forum is designed for educational purposes only, and experts are not rendering medical, mental health, legal or other professional advice or services. If you have or suspect you may have a medical, mental health, legal or other problem that requires advice, consult your own caregiver, attorney or other qualified professional.
Experts appearing on this page are independent and are solely responsible for editing and fact-checking their material. Neither TheBody.com nor any advertiser is the publisher or speaker of posted visitors' questions or the experts' material.
Review our complete terms of use and copyright notice.
